1.  mid life
2.  "completely well before"
3. Corticosteroid = magic pill
4. antibiotic seeking
5. polyps
6. LM score 24
7. Oesinophilia > 10eos/hpf often > 100
8. Serum oesinphilia
9. repeated systemic steroid
10. steroid irrigations
11. Zileuton
12. Montileukast, Zafirlukast
13. Can take selective COX-2 inhibitors
14. Difficult to treat Mepoluzimab, Benraluzimab, Dupilumab, Resiluzumab
15. ASA desensitisation
  
  [[EPOS Executive Summary]]
  [[endotypes in sinusitis]]
  [[phenotype]]
  [[Different types of phenotypes of CRS]]

### Flashcards #flashcards/rhinology

What is the typical age of onset for eCRS?::Mid-life. (Source: [[eCRS]])
<!--SR:!2025-11-25,31,270-->

How do patients with eCRS typically describe their health status before the onset of the disease?::"Completely well before". (Source: [[eCRS]])
<!--SR:!2025-11-23,29,270-->

What is the characteristic response of eCRS to corticosteroids?::They act as a "magic pill," providing significant, though often temporary, relief. (Source: [[eCRS]])
<!--SR:!2025-11-22,28,270-->

A key clinical finding on examination in a patient with eCRS is the presence of ==nasal polyps==. (Source: [[eCRS]])
<!--SR:!2025-11-20,26,270-->

What level of tissue eosinophilia is a hallmark of eCRS?::Greater than 10 eosinophils per high-power field (>10 eos/hpf), and often >100. (Source: [[eCRS]])
<!--SR:!2025-11-21,27,270-->

Name three biologic treatments for difficult-to-treat eCRS. (Source: [[eCRS]])
?
- Mepolizumab
- Benralizumab
- Dupilumab
- Reslizumab
<!--SR:!2025-11-06,12,271-->

Patients with Aspirin-Exacerbated Respiratory Disease (AERD) can often safely take which class of pain medication?::Selective COX-2 inhibitors. (Source: [[eCRS]])
<!--SR:!2025-11-23,29,270-->

What is a potential treatment for patients with AERD that involves controlled administration of aspirin?::ASA (Aspirin) desensitisation. (Source: [[eCRS]])
<!--SR:!2025-11-24,30,270-->

What class of medication do Montelukast and Zafirlukast belong to, which are used in eCRS management?::Leukotriene receptor antagonists. (Source: [[eCRS]])
<!--SR:!2025-12-08,44,290-->